BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Mylan N.V. Announces Commencement Of Secondary Public Offering Of A Portion Of Abbott (ABT)'s Ordinary Shares 3/30/2015
Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB) 3/30/2015
Can-Fite BioPharma (CFBI) Files 2014 Annual Report On Form 20-F 3/30/2015
Covalon Technologies Ltd. Announces Issuance Of Stock Options 3/30/2015
Eli Lilly (LLY) Announces Date For Diabetes Investor Meeting 3/30/2015
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015
MultiVir Files Registration Statement For Proposed Initial Public Offering 3/30/2015
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application 3/30/2015
Coherus Biosciences Announces Proposed Public Offering Of Common Stock 3/30/2015
Trillium Therapeutics Announces Proposed Public Offering Of Securities 3/30/2015
Insmed Incorporated (INSM) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/30/2015
Raptor Pharmaceutical Inc. (RPTP) Announces Proposed Public Offering Of Common Stock 3/30/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results 3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
SurePure Completes Verification And Approved For Trading On The OTCQB Marketplace 3/27/2015
Galapagos (GLPG.BR) Release: Publication Of Annual Report 2014 And Invitation To The Annual Shareholders' Meeting To Be Held On 28 April 2015 3/27/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/27/2015
Synergy Pharmaceuticals May Be for Sale 3/27/2015
Johnson & Johnson (JNJ) To Webcast Annual Meeting Of Shareholders 3/27/2015
Valeant (VRX) Closes Offering Of $1.45 Billion Of Common Shares 3/27/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund 3/26/2015
Why Your Last Investment Blew Up 3/26/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 3/26/2015
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015
Notice Of Annual General Meeting In Biotage AB (BIOTa.ST) (Publ) 3/26/2015
Becton, Dickinson and Company (BDX) To Commence Exchange Offers 3/26/2015
Novavax, Inc. (NVAX) Prices Public Offering Of Common Stock 3/26/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Prices Public Offering Of Common Stock By Selling Stockholders 3/26/2015
SteadyMed (STDY) Announces Closing of Initial Public Offering 3/26/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Proposed Public Offering By Selling Stockholders 3/26/2015
Cardica, Inc. (CRDC) To Host Business Update Conference Call 3/26/2015
Omnicell Receives Expected Nasdaq Notification Of Noncompliance 3/25/2015
Haemonetics Corporation (HAE) Sets Date For Investor/Analyst Meeting - May 19, 2015 3/25/2015
ZS Pharma (ZSPH) Announces Upsizing And Pricing Of $186 Million Public Offering Of Common Stock 3/25/2015
Novavax, Inc. (NVAX) Announces Proposed Public Offering Of Common Stock 3/25/2015
Oxis Biotech Inc. Announces Corporate Update Conference Call For March 31 3/25/2015
EPIRUS Biopharmaceuticals To Host Biosimilar Key Opinion Leader Meeting And Webcast On March 30 3/25/2015
Nasdaq Welcomes Cellectis (ALCLS) The Nasdaq Stock Market 3/25/2015
Tekmira (TKMR) Announces Completion Of Underwritten Public Offering Of Common Shares 3/25/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Nolato AB ( NOLA-B.ST): Notice Of The 2015 Annual General Meeting 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/25/2015
Cellectis (ALCLS) Prices Initial Public Offering Of American Depositary Shares 3/25/2015
Merck & Co. (MRK) Announces New $10 Billion Share Repurchase Program 3/25/2015
Retrophin (RTRX) Closes Public Offering Of 7,866,000 Shares Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 3/25/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Completion Of Public Offering 3/25/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Buy This Stock to Bet on Biogen (BIIB) Drug, Says Raymond James & Associates 3/24/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock 3/24/2015
Blueprint Medicines Files Registration Statement for Proposed Initial Public Offering 3/24/2015
ZS Pharma (ZSPH) Announces Proposed Public Offering Of Common Stock 3/24/2015
InVivo Therapeutics Corporation (NVIV) Announces Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ 3/24/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts 3/24/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Lpath, Inc. (LPTN) To Hold Investor Update Conference Call 3/23/2015
Capstone Therapeutics (CAPS) Announces Operating Update Conference Call 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015
AtriCure, Inc. (ATRC) To Ring The Nasdaq Stock Market Closing Bell 3/23/2015
Sterigenics International, Inc. Announces Recapitalization With Warburg Pincus And GTCR 3/23/2015
OXiGENE (OXGN) Announces $10 Million At-the-Market Registered Direct Offering 3/20/2015
Tekmira (TKMR) Announces Pricing Of Underwritten Public Offering Of Common Shares 3/20/2015
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015
CorMedix (CRMD) Announces Effectiveness Of Registration Statements For Shares Underlying Publicly Traded Warrants 3/20/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/20/2015
Tekla Life Sciences Investors Announce Renewal Of Share Repurchase Program 3/20/2015
SciClone Pharmaceuticals, Inc. (SCLN) To Present At Investor And Partnering Conferences In China 3/20/2015
Theravance (THRX) Announces Trading In Common Stock Halted 3/20/2015
Retrophin (RTRX) Prices Public Offering Of 6,840,000 Shares Of Common Stock 3/19/2015
Agilent Technologies Inc. (A) Announces Cash Dividend Of 10 Cents Per Share 3/19/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Proposed Public Offering Of Common Stock 3/19/2015
Assembly Biosciences Announces Pricing Of $75 Million Public Offering Of Its Common Stock 3/19/2015
Summit Therapeutics Announces Exercise of Over-Allotment Option 3/19/2015
Tekmira (TKMR) Announces Proposed Public Offering Of Common Shares 3/19/2015
Assembly Biosciences Announces Proposed Public Offering Of Common Stock 3/19/2015
Galena Biopharma  (GALE) Announces Closing Of Public Offering Of Common Stock And Warrants 3/19/2015
Intellect Neurosciences, Inc. Issues Letter To Shareholders 3/19/2015
Esperion Therapeutics (ESPR) Prices Public Offering Of Common Stock 3/19/2015
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015
Rhinomed (ASX:RNO) Investor Newsletter 3/19/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Pricing Of Public Offering 3/19/2015
Juno Therapeutics (JUNO) Post IPO: Ups and Downs But Mostly Ups 3/18/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Proposed Public Offering Of Common Stock 3/18/2015
TetraPhase Pharmaceuticals (TTPH) Announces Closing Of Public Offering Of Common Stock 3/18/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Pricing Of Public Offering Of Common Stock 3/18/2015
Lixte Biotechnology Completes Private Placement Of Convertible Preferred Stock 3/18/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 3/18/2015
Avalanche Biotechnologies (AAVL) To Host Analyst And Investor Day On March 25, 2015 3/18/2015
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/18/2015
Celator Pharmaceuticals, Inc. Announces Business Update And Fourth Quarter And Full Year 2014 Financial Results 3/18/2015
Esperion Therapeutics (ESPR) Announces Proposed Public Offering Of Common Stock 3/18/2015
Admedus Announces Placement And Rights Issue 3/18/2015
ADMA Biologics, Inc. Announces Closing Of Public Offering Of Common Stock And Exercise Of Over-Allotment Option In Full 3/18/2015
Election Of New Board Members By Extraordinary General Meeting Of Cortendo AB 3/18/2015
Omnicell Provides Update On Form 10-K Filing And Reaffirms 2015 Financial Guidance 3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst 3/17/2015
Epizyme (EPZM) Eyes $100 Million for Mid-Stage Trials of a Reacquired Drug 3/17/2015
Johnson & Johnson (JNJ) Announces Strategic Investment Alliance To Combat Dementia Globally 3/17/2015
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015
Kythera (KYTH) Announces Closing Of Public Offering And Exercise Of Underwriters' Over-Allotment Option 3/17/2015
Bellerophon Therapeutics (BLPH) To Ring The NASDAQ Stock Market Closing Bell 3/17/2015
Heat Biologics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of The Underwriters' Over-Allotment Option 3/17/2015
Genocea Biosciences Announces Closing Of $51.7 Million Public Offering Of Common Stock And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares 3/17/2015
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results 3/17/2015
Eagle Pharmaceuticals (EGRX) Announces Pricing Of Public Offering Of Common Stock 3/17/2015
OncoSec Medical Inc. CEO Punit Dhillon To Host Live Webinar To Provide Corporate Update And 2015 Outlook 3/17/2015
Retrophin (RTRX) Announces Proposed Public Offering Of 5,100,000 Shares Of Common Stock 3/17/2015
Eagle Pharmaceuticals (EGRX) Announces Commencement Of Public Offering Of Common Stock 3/17/2015
Horizon Pharma plc.  (HZNP) Closes Offering Of $400 Million Of 2.50% Exchangeable Senior Notes, Including Exercise In Full Of Option To Purchase Additional Notes 3/17/2015
Oculus Innovative Sciences, Inc. (OCLS) Announces Sale Of 350,000 Shares Of Ruthigen Stock For $962,500 In Non-Dilutive Funding 3/16/2015
Polar Capital Funds Plc And Fmr Llc Provide Notification Of Shareholding In Ablynx (ABLYF) 3/16/2015
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/16/2015
IMS Health Announces Offering Of Senior Notes To Finance Proposed Acquisition Of Cegedim SA’s CRM And Strategic Data Businesses 3/16/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 3/16/2015
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 3/16/2015
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015
Ablynx (ABLYF) Announces Warrant Exercise 3/16/2015
Washington State Court Issues Order Requiring Acucela To Hold Special Shareholders Meeting 3/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS 3/16/2015
Depomed, Inc. (DEPO) Nabs $575 Million Debt Facility From Deerfield, Pharmakon Advisors 3/13/2015
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 3/13/2015
Galena Biopharma  (GALE) Announces Proposed Public Offering Of Common Stock And Warrants 3/13/2015
ADMA Biologics, Inc. Announces Proposed Public Offering Of Common Stock 3/13/2015
Galena Biopharma  (GALE) Announces Pricing Of Public Offering Of Common Stock And Warrants 3/13/2015
Replicel Life Sciences In Japan For Key Industry Meetings 3/12/2015
TetraPhase Pharmaceuticals (TTPH) Announces Pricing Of Public Offering Of Common Stock 3/12/2015
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015
Intra-Cellular Therapies, Inc. Announces Closing Of $130 Million Public Offering Including Exercise Of Underwriters' Option To Purchase Additional Shares 3/12/2015
Raptor Pharmaceutical Inc. (RPTP) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/12/2015
Genocea Biosciences Announces Pricing Of $45 Million Public Offering 3/12/2015
Acucela Files Opposition To SBI/Kubota Motion To Compel Company To Call Special Shareholders Meeting 3/12/2015
Champions Oncology, Inc. (CSBR) Announces $14 Million Capital Raise 3/12/2015
Mylan N.V. And Mylan Inc. (MYL) Announce Successful Completion Of Consent Solicitations For Mylan Inc.'s Notes 3/12/2015
Medivir AB (MVRBF) Capital Markets Meeting On 26 March 2015 3/12/2015
Actavis (ACT) Announces Closing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/12/2015
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 3/12/2015
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 3/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 3/11/2015
Heat Biologics Announces Proposed Public Offering Of Common Stock 3/11/2015
Heat Biologics Announces Pricing Of Public Offering Of $10,660,000 Of Common Stock 3/11/2015
Kythera (KYTH) Announces Pricing Of Public Offering Of Common Stock 3/11/2015
Lonza Group Ltd. (LZAGY.PK) Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting 3/11/2015
SYGNIS AG To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015
Aequus Pharmaceuticals Receives Conditional Approval To Commence Trading On TSX-V Exchange 3/11/2015
Auris Medical AG (EARS) To Host Key Opinion Leader Meeting On Tinnitus Treatments On March 13 In New York City 3/11/2015
CryoPort, Inc. Co-Sponsors The Alliance For Regenerative Medicine 3rd Annual REGENMED Investor Day 3/11/2015
Tenax Therapeutics (TENX) To Provide Corporate Update And Discuss Third Quarter Fiscal Year 2015 Financial Results On March 18, 2015 3/11/2015
BioLineRx Ltd. Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 3/11/2015
Actavis (ACT) And Allergan (AGN) Shareholders Approve Proposals Related To Actavis' Planned Acquisition Of Allergan 3/11/2015
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 3/10/2015
HEALTHSOUTH Announces Pricing Of $300 Million Senior Notes Offering 3/10/2015
TetraPhase Pharmaceuticals (TTPH) Announces Proposed Public Offering Of Common Stock 3/10/2015
Tesaro, Inc. (TSRO) Announces Closing Of Public Offering Of Common Stock And Exercise Of Over-Allotment Option By Underwriters 3/10/2015
Kythera (KYTH) Announces Proposed Public Offering Of Common Stock 3/10/2015
Portola Pharmaceuticals, Inc. Announces Proposed Offering Of Common Stock 3/10/2015
Portola Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock 3/10/2015
PharmAthene, Inc. (PIP) Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign Operational Resources 3/10/2015
Opexa Therapeutics (OPXA) Reminds Shareholders That Rights Offering Ownership Date And Time Is Tuesday, March 10, 2015 At 4:00 PM ET 3/10/2015
Catalent, Inc. Closes Secondary Public Offering Of Common Stock 3/10/2015
NanoViricides, Inc. (NNVC.PK) Issued Registered Shares As Interest To Certain Debenture Holders 3/9/2015
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015
HEALTHSOUTH Announces Launch Of $300 Million Senior Notes Offering Due 2023 And Intent To Redeem $290 Million Of Senior Notes Due 2020 3/9/2015
Flex Pharma (FLKS) Announces Establishment Of Stock Purchase Plan By Chief Executive Officer 3/9/2015
ProtoKinetix Inc. (PKTX.OB) Announces Settlement Of Debt 3/9/2015
Microbix Biosystems Inc. (MBXBF) Announces Annual And Special Meeting Voting Results 3/9/2015
Takeda Pharmaceutical Co. Ltd. (TKPYY) Hosts Investor Briefing On Its Global Leadership In Gastroenterology 3/9/2015
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015
ProtoKinetix Inc. (PKTX.OB) Announces Share Issuance And Closing Of West Vancouver Office 3/9/2015
AEterna Zentaris (AEZS) Announces Proposed Public Offering Of Common Shares And Warrants 3/6/2015
DuPont (DD) Leader Highlights Strategy, Progress And Plans To Accelerate Growth In Advanced Materials And Discusses Near-Term Outlook 3/6/2015
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015
BioLife Solutions, Inc. (BLFS.OB) To Report Fourth Quarter And Full Year 2014 Financial Results And Provide Business Update On March 12, 2015 3/6/2015
AmerisourceBergen Corporation (ABC) Announces Results Of Annual Meeting Of Stockholders 3/6/2015
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index 3/6/2015
PhytoTech Medical Limited (ASX:PYL) Investor Presentation 3/6/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib 3/5/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 3/5/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Grants Stock Options Under Inducement Program 3/5/2015
Summit Therapeutics To Ring The Nasdaq Stock Market Closing Bell 3/5/2015
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustment For Convertible Note 3/5/2015
Tandem Diabetes Care Announces Closing Of Underwritten Public Offering Of Common Stock 3/5/2015
Nuvo Research Inc. (NRI.TO) Provides Business Update 3/5/2015
Capricor Therapeutics, Inc. Announces Uplisting To NASDAQ Capital Market 3/5/2015
ABC Laboratories, Inc. Announces Completion Of EPA GLP Audit 3/5/2015
Epizyme (EPZM) To Report Fourth Quarter 2014 Financial Results And Provide Corporate Update On March 12, 2015 3/5/2015
Horizon Pharma plc.  (HZNP) Announces Proposed Offering Of $300 Million Of Exchangeable Senior Notes 3/5/2015
Actavis (ACT) Announces Pricing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/4/2015
Lexicon Pharmaceuticals, Inc. (LXRX) Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results 3/4/2015
AMAG Pharmaceuticals, Inc. (AMAG) Announces Closing Of $201 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option 3/4/2015
Relypsa, Inc. (RLYP) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Public Offering Of Common Stock 3/4/2015
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Pricing Of Public Offering Of Common Stock 3/4/2015
Tesaro, Inc. (TSRO) Announces Pricing Of Public Offering Of Common Stock 3/4/2015